Bicalutamide and Alcohol: Interaction Risks and Clinical Advice

Interaction

Alcohol does not have a direct pharmacokinetic interaction with bicalutamide (a non-steroidal antiandrogen), but both are hepatically metabolized and can independently cause liver injury.

Risks of Combined Use

  • Additive hepatotoxicity: Increased risk of elevated transaminases, hepatitis, or liver failure.
  • Worsening of side effects: Fatigue, hot flashes, GI upset may be exacerbated.
  • Compliance: Alcohol may impair adherence to daily dosing.

Clinical Recommendation

  • Avoid or strictly limit alcohol during bicalutamide therapy.
  • Monitor LFTs (ALT, AST, bilirubin) at baseline, periodically, and with symptoms.
  • Report jaundice, dark urine, RUQ pain, unexplained fatigue immediately.

Context

Bicalutamide is used for prostate cancer (often with LHRH agonist) or as monotherapy. Liver toxicity is rare but serious; alcohol unnecessarily increases risk.

Drug Addiction - Related Articles